The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation

Anaesthesia

Volumn 53, Issue 7, 1998, Pages 638-644

  Jamnicki, M ^a   Zollinger, A ^a   Seifert, B ^b   Popovic, D ^a   Pasch, T ^a   Spahn, D R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Blood; coagulation, replacement, hydroxyethyl starch

Indexed keywords

HETASTARCH; INFUKOLL HES; POTATO STARCH; STARCH; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODILUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; THROMBOELASTOGRAPHY;

ADULT; AGED; BLOOD COAGULATION; CALCIUM; FEMALE; HEMODILUTION; HEMOGLOBINS; HETASTARCH; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; SOLANUM TUBEROSUM; THROMBELASTOGRAPHY; ZEA MAYS;

EID: 0031828394     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1998.489-az0565.x     Document Type: Article

References (27)

1. Spahn DR, Leone BJ, Reves JG, Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesthesia and Analgesia 1994; 78: 1000-21.
2. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. British Journal of Surgery 1992; 79: 513-6.
3. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 1995; 35: 719-22.
4. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesthesia and Analgesia 1992; 74: 219-25.
5. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesthesia and Analgesia 1993; 76: 1185-90.
6. Ruttmann TG, James MF, Viljoen JF Haemodilution induces a hypercoagulable state. British Journal of Anaesthesia 1996; 76: 412-4.
7. Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. British Journal of Anaesthesia 1997; 78: 684-9.
8. Dunn EL, Moore EE, Breslich DJ, Galloway WB. Acidosis-induced coagulopathy. Surgical Forum 1979; 30: 471-3.
9. Bithell TC. Role of metal ions. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobes Clinical Hematology. Philadelphia: Lea & Febiger 1993; 587.
10. Gubler KD, Gentilello LM, Hassantash SA, Maier RV. The impact of hypothermia on dilutional coagulopathy. Journal of Trauma 1994; 36: 847-51.
11. Mallett SV, Cox DJ. Thrombelastography. British Journal of Anaesthesia 1992; 69: 307-13.
12. Caprini JA, Zuckerman L, Cohen E, Vagher JP, Lipp V. The identification of accelerated coagulability. Thrombosis Research 1976; 9: 167-80.
13. Sharma SK, Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesthesia and Analgesia 1997; 85: 94-8.
14. Sommermeyer K. Vergleichende physikochemische Untersuchungen an Hydroxyethylstärken 200/0,5. Krankenhauspharmazie 1992; 12: 580-4.
15. Egli GA, Spahn DR. Does hemodilution enhance or compromise blood coagulation. Seminars in Cardiothoracic and Vascular Anesthesia 1997; 1: 342-8.
16. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 28: 257-60.
17. Treib J, Haass A, Pindur G, et al. Influence of low molecular weight hydroxyethyl starch (HES 40/0.5-0.55) on hemostasis and hemorheology. Haemostasis 1996; 26: 258-65.
18. Koscielny J, Jung F, Mrowietz C, et al. Vergleich von zwei 6%igen mittelmolekularen Hydroxyäthylstärkelösungen auf die Eliminationskinetik und die Fließfähigkeit des Blutes bei freiwilligen Probanden. Infusionstherapie und Transfusionsmedizin 1994; 21: 251-9.
19. Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996; 36: 450-5.
20. Treib J, Haass A, Pindur G, et al. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneimittelforschung 1997; 47: 18-22.
21. Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thrombosis and Haemostasis 1995; 74: 1452-6.
22. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not? Anesthesia and Analgesia 1997; 84: 206-12.
23. Janvrin SB, Davies G, Greenhalgh RM. Postoperative deep vein thrombosis caused by intravenous fluids during surgery. British Journal of Surgery 1980; 67: 690-3.
24. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Effects of progressive blood loss on coagulation as measured by thrombelastography. Anesthesia and Analgesia 1987; 66: 856-63.
25. Ng KF, Lo JW. The development of hypercoagulability state, as measured by thrombelastography, associated with intraoperative surgical blood loss. Anaesthesia and Intensive Care 1996; 24: 20-5.
26. Strauss RG, Stump DC, Henriksen RA, Saunders R. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985; 25: 230-4.
27. Carr M Jr. Effect of hydroxyethyl starch on the structure of thrombin- and reptilase-induced fibrin gels. Journal of Laboratory and Clinical Medicine 1986; 108: 556-61.